tiprankstipranks
Trending News
More News >
CVS Health Corp (IT:1CVS)
:1CVS
Italy Market

CVS Health (1CVS) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

1CVS Analyst Ratings

Strong Buy
19Ratings
16 Buy
3 Hold
0 Sell
Based on 19 analysts giving stock ratings to
CVS
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1CVS Stock 12 Month Forecast

Average Price Target

€70.91
▲(28.36% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is €70.91 with a high forecast of €84.91 and a low forecast of €63.46. The average price target represents a 28.36% change from the last price of €55.24.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"41":"€41","52":"€52","63":"€63","74":"€74","85":"€85"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":84.91483515,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€84.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.9083565521,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€70.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":63.46266627,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€63.46</span>\n  </div></div>","useHTML":true}}],"tickPositions":[41,52,63,74,85],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.54,60.56883347307692,62.59766694615384,64.62650041923077,66.6553338923077,68.68416736538461,70.71300083846154,72.74183431153847,74.77066778461538,76.7995012576923,78.82833473076923,80.85716820384616,82.88600167692307,{"y":84.91483515,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.54,59.49141204246923,60.44282408493846,61.394236127407694,62.345648169876924,63.29706021234615,64.24847225481538,65.19988429728461,66.15129633975384,67.10270838222308,68.05412042469231,69.00553246716154,69.95694450963077,{"y":70.9083565521,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,58.54,58.918666636153844,59.29733327230769,59.675999908461534,60.05466654461539,60.43333318076923,60.81199981692308,61.19066645307692,61.56933308923077,61.94799972538461,62.326666361538464,62.70533299769231,63.083999633846155,{"y":63.46266627,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":60.41,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.584,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.706,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.641,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.133,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.757,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.729,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.954,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.22,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.949,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.912,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.219,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.54,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€84.91Average Price Target€70.91Lowest Price Target€63.46
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan
€71.98€76.42
Buy
38.34%
Upside
Reiterated
05/07/25
Evercore ISI
€75.53
Buy
36.73%
Upside
Reiterated
05/07/25
Accountability Research Analyst forecast on IT:1CVS
Unknown Analyst
Not Ranked
Accountability Research
€65.76
Buy
19.04%
Upside
Upgraded
05/06/25
Cantor Fitzgerald
€63.09
Buy
14.21%
Upside
Reiterated
05/05/25
Argus Research
Buy
Reiterated
05/05/25
Wells Fargo
€67.53€74.64
Buy
35.12%
Upside
Reiterated
05/05/25
TD Cowen
€79.97€84.42
Buy
52.82%
Upside
Reiterated
05/05/25
RBC Capital
€65.76€71.98
Buy
30.30%
Upside
Reiterated
05/04/25
Truist Financial
€72.87
Buy
31.91%
Upside
Reiterated
05/02/25
Bank of America Securities
€71.09€75.53
Buy
36.73%
Upside
Reiterated
05/02/25
UBS
€59.54€63.09
Hold
14.21%
Upside
Reiterated
05/02/25
Barclays
€64.87€72.87
Buy
31.91%
Upside
Reiterated
05/02/25
Leerink Partners
€70.2€73.75
Buy
33.52%
Upside
Reiterated
05/01/25
Morgan Stanley
€60.43€71.09
Buy
28.69%
Upside
Reiterated
04/15/25
Robert W. Baird
€45.32€63.09
Hold
14.21%
Upside
Reiterated
04/15/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan
€71.98€76.42
Buy
38.34%
Upside
Reiterated
05/07/25
Evercore ISI
€75.53
Buy
36.73%
Upside
Reiterated
05/07/25
Accountability Research Analyst forecast on IT:1CVS
Unknown Analyst
Not Ranked
Accountability Research
€65.76
Buy
19.04%
Upside
Upgraded
05/06/25
Cantor Fitzgerald
€63.09
Buy
14.21%
Upside
Reiterated
05/05/25
Argus Research
Buy
Reiterated
05/05/25
Wells Fargo
€67.53€74.64
Buy
35.12%
Upside
Reiterated
05/05/25
TD Cowen
€79.97€84.42
Buy
52.82%
Upside
Reiterated
05/05/25
RBC Capital
€65.76€71.98
Buy
30.30%
Upside
Reiterated
05/04/25
Truist Financial
€72.87
Buy
31.91%
Upside
Reiterated
05/02/25
Bank of America Securities
€71.09€75.53
Buy
36.73%
Upside
Reiterated
05/02/25
UBS
€59.54€63.09
Hold
14.21%
Upside
Reiterated
05/02/25
Barclays
€64.87€72.87
Buy
31.91%
Upside
Reiterated
05/02/25
Leerink Partners
€70.2€73.75
Buy
33.52%
Upside
Reiterated
05/01/25
Morgan Stanley
€60.43€71.09
Buy
28.69%
Upside
Reiterated
04/15/25
Robert W. Baird
€45.32€63.09
Hold
14.21%
Upside
Reiterated
04/15/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

Which Analyst Should I Follow If I Want to Buy IT:1CVS and Sell After:
1 Month
xxx
Success Rate
18/27 ratings generated profit
67%
Average Return
+1.36%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +1.36% per trade.
3 Months
xxx
Success Rate
13/21 ratings generated profit
62%
Average Return
+2.12%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.90% of your transactions generating a profit, with an average return of +2.12% per trade.
1 Year
Michael ChernyLeerink Partners
Success Rate
16/32 ratings generated profit
55%
Average Return
+6.27%
reiterated a buy rating 14 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 54.84% of your transactions generating a profit, with an average return of +6.27% per trade.
2 Years
xxx
Success Rate
15/21 ratings generated profit
71%
Average Return
+15.41%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 71.43% of your transactions generating a profit, with an average return of +15.41% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1CVS Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
4
4
2
0
0
Buy
30
31
32
35
29
Hold
11
7
4
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
45
42
38
38
31
In the current month, 1CVS has received 29 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 1CVS average Analyst price target in the past 3 months is 70.91.
Each month's total comprises the sum of three months' worth of ratings.

1CVS Financial Forecast

1CVS Earnings Forecast

Next quarter’s earnings estimate for 1CVS is €1.31 with a range of €1.17 to €1.54. The previous quarter’s EPS was €2.01. 1CVS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.99% of the time in the same period. In the last calendar year 1CVS has Preformed in-line its overall industry.
Next quarter’s earnings estimate for 1CVS is €1.31 with a range of €1.17 to €1.54. The previous quarter’s EPS was €2.01. 1CVS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.99% of the time in the same period. In the last calendar year 1CVS has Preformed in-line its overall industry.

1CVS Sales Forecast

Next quarter’s sales forecast for 1CVS is €84.83B with a range of €81.14B to €88.26B. The previous quarter’s sales results were ―. 1CVS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 50.97% of the time in the same period. In the last calendar year 1CVS has Preformed in-line its overall industry.
Next quarter’s sales forecast for 1CVS is €84.83B with a range of €81.14B to €88.26B. The previous quarter’s sales results were ―. 1CVS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 50.97% of the time in the same period. In the last calendar year 1CVS has Preformed in-line its overall industry.

1CVS Stock Forecast FAQ

What is IT:1CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is 70.91.
    What is IT:1CVS’s upside potential, based on the analysts’ average price target?
    CVS Health Corp has 28.36% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CVS Health Corp a Buy, Sell or Hold?
          CVS Health Corp has a consensus rating of Strong Buy, which is based on 16 buy ratings, 3 hold ratings and 0 sell ratings.
            What is CVS Health Corp’s share price target?
            The average share price target for CVS Health Corp is 70.91. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €84.91 ,and the lowest forecast is €63.46. The average share price target represents 28.36% Increase from the current price of €55.24.
              What do analysts say about CVS Health Corp?
              CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of CVS Health Corp?
                To buy shares of IT:1CVS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis